Level C· Early human research exploring benefitsProspective StudyPubMed

[Bone Marrow Adipocytes Promote the Survival of Multiple Myeloma Cells and Up-Regulate Their Chemoresistance].

Wei XQ., Zhang YM., Sun Y., Ling HY., He YN., Fu JX.

Prospective Study, published in Zhongguo Shi Yan Xue Ye Xue Za Zhi (2023) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Zhongguo Shi Yan Xue Ye Xue Za Zhi (2023)
Country
China
Reported sample size
—
Source database
PubMed
PMID
36765493
DOI
10.19746/j.cnki.issn.1009-2137.2023.01.025

Abstract (original English)

To investigate the effect of adipocytes in the bone marrow microenvironment of patients with multiple myeloma (MM) on the pathogenesis of MM. Bone marrow adipocytes (BMA) in bone marrow smears of health donors (HD) and newly diagnosed MM (ND-MM) patients were evaluated with oil red O staining. The mesenchymal stem cells (MSC) from HD and ND-MM patients were isolated, and in vitro co-culture assay was used to explore the effects of MM cells on the adipogenic differentiation of MSC and the role of BMA in the survival and drug resistance of MM cells. The expression of adipogenic/osteogenic differentiation-related genes PPAR-γ , DLK1 , DGAT1 , FABP4 , FASN and ALP both in MSC and MSC-derived adipocytes was determined with real-time quantitative PCR. The Western blot was employed to detect the expression levels of IL-6, IL-10, SDF-1α, TNF-α and IGF-1 in the supernatant with or without PPAR-γ inhibitor. The results of oil red O staining of bone marrow smears showed that BMA increased significantly in patients of ND-MM compared with the normal control group, and the BMA content was related to the disease status. The content of BMA decreased in the patients with effective chemotherapy. MM cells up-regulated the expression of MSC adipogenic differentiation-related genes PPAR-γ , DLK1 , DGAT1 , FABP4 and FASN , but the expression of osteogenic differentiation-related gene ALP was signifi

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansOsteogenesisBone MarrowMultiple MyelomaDrug Resistance, NeoplasmPeroxisome Proliferator-Activated ReceptorsCell DifferentiationAdipogenesisCytokinesAdipocytes

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.